Omeros - Stock Price History | OMER

Historical daily share price chart and data for Omeros since 2020 adjusted for splits. The latest closing stock price for Omeros as of October 23, 2020 is 10.66.
  • The all-time high Omeros stock closing price was 26.69 on September 04, 2018.
  • The Omeros 52-week high stock price is 25.46, which is 138.8% above the current share price.
  • The Omeros 52-week low stock price is 8.50, which is 20.3% below the current share price.
  • The average Omeros stock price for the last 52 weeks is 13.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Omeros Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 16.0534 11.8500 20.5600 11.6500 14.0900 26.48%
2018 16.9450 20.1550 26.6900 9.0000 11.1400 -42.67%
2017 17.1065 10.1000 26.5800 8.9500 19.4300 95.87%
2016 11.5152 14.7900 16.3700 7.3400 9.9200 -36.94%
2015 18.3820 25.0100 26.3500 10.9000 15.7300 -36.52%
2014 14.3080 12.0600 24.7800 9.9400 24.7800 119.49%
2013 6.4532 5.3900 13.2300 3.7600 11.2900 117.53%
2012 8.6929 4.0000 13.2500 3.9900 5.1900 31.39%
2011 4.8167 8.5000 8.5000 3.1700 3.9500 -52.06%
2010 6.8037 7.2900 8.7700 5.2400 8.2400 17.38%
2009 7.0094 8.7300 8.7300 5.4000 7.0200 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.602B $0.112B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $193.838B 34.76
Medtronic (MDT) Ireland $150.337B 28.31
Stryker (SYK) United States $84.201B 32.65
Boston Scientific (BSX) United States $52.735B 30.46
Lonza Group Ag (LZAGY) Switzerland $46.915B 0.00
Baxter (BAX) United States $41.233B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.618B 24.58
EssilorLuxottica Societe Anonyme (ESLOY) France $29.595B 0.00
Terumo (TRUMY) Japan $28.421B 36.33
ResMed (RMD) United States $26.492B 38.41
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Bio-Rad Laboratories (BIO) United States $17.185B 77.72
Smith & Nephew SNATS (SNN) United Kingdom $16.848B 0.00
Insulet (PODD) United States $16.101B 681.25
DiaSorin S.p.A (DSRLF) Italy $12.588B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.309B 54.61
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $7.547B 0.00
Perrigo (PRGO) Ireland $6.207B 10.65
Hill-Rom Holdings (HRC) United States $6.066B 15.05
Haemonetics (HAE) United States $5.406B 36.02
Envista Holdings (NVST) United States $4.393B 29.96
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.124B 0.00
ICU Medical (ICUI) United States $4.064B 31.01
Abcam (ABCZY) $3.897B 0.00
Neogen (NEOG) United States $3.787B 62.09
TG Therapeutics (TGTX) United States $3.474B 0.00
National Vision Holdings (EYE) United States $3.425B 532.38
GW Pharmaceuticals (GWPH) United Kingdom $3.013B 0.00
Agios Pharmaceuticals (AGIO) United States $2.686B 0.00
NuVasive (NUVA) United States $2.649B 36.91
DFB Healthcare Acquisitions (AHCO) United States $2.230B 0.00
AtriCure (ATRC) United States $1.720B 0.00
Owens & Minor (OMI) United States $1.548B 34.67
Cardiovascular Systems (CSII) United States $1.541B 0.00
NanoString Technologies (NSTG) United States $1.393B 0.00
Aphria (APHA) Canada $1.351B 0.00
InMode (INMD) Israel $1.336B 33.71
MacroGenics (MGNX) United States $1.227B 0.00
Quanterix (QTRX) United States $1.162B 0.00
OraSure Technologies (OSUR) United States $1.057B 0.00
Cerus (CERS) United States $1.049B 0.00
BioLife Solutions (BLFS) United States $0.915B 476.33
Lantheus Holdings (LNTH) United States $0.869B 12.05
PetIQ (PETQ) United States $0.869B 24.92
Vapotherm (VAPO) United States $0.801B 0.00
Meridian Bioscience (VIVO) United States $0.785B 18.14
Phibro Animal Health (PAHC) United States $0.737B 16.86
LeMaitre Vascular (LMAT) United States $0.657B 40.11
Eagle Pharmaceuticals (EGRX) United States $0.646B 91.33
Varex Imaging (VREX) United States $0.560B 24.29
Aurora Cannabis (ACB) Canada $0.560B 0.00
Surmodics (SRDX) United States $0.556B 60.99
Zynex (ZYXI) United States $0.494B 43.15
Viemed Healthcare (VMD) United States $0.377B 13.40
HEXO (HEXO) $0.364B 0.00
Cytosorbents (CTSO) United States $0.356B 0.00
Surface Oncology (SURF) United States $0.352B 0.00
Utah Medical Products (UTMD) United States $0.306B 26.25
InfuSystems Holdings (INFU) United States $0.268B 51.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.243B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.219B 0.00
Bovie Medical (APYX) United States $0.212B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.182B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Female Health (VERU) United States $0.170B 0.00
Fonar (FONR) United States $0.138B 18.26
Liberty Health Sciences (LHSIF) United States $0.127B 0.00
Evolus (EOLS) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Capricor Therapeutics (CAPR) United States $0.090B 0.00
Rockwell Medical (RMTI) United States $0.070B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.069B 0.00
United-Guardian (UG) United States $0.068B 15.19
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 11.86
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.060B 0.00
MTech Acquisition (KERN) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Myomo (MYO) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00